HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fever (Fevers)

An abnormal elevation of body temperature, usually as a result of a pathologic process.
Also Known As:
Fevers; Pyrexia; Pyrexias
Networked: 39160 relevant articles (1820 outcomes, 2480 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pain (Aches)
2. Infections
3. Cough
4. Neutropenia
5. Inflammation (Inflammations)

Experts

1. Roth, Joachim: 35 articles (01/2022 - 01/2002)
2. Romanovsky, Andrej A: 32 articles (01/2022 - 01/2002)
3. Ammann, Roland A: 32 articles (12/2021 - 11/2003)
4. Wang, Wei: 31 articles (01/2022 - 05/2004)
5. Branco, Luiz G S: 29 articles (10/2020 - 02/2002)
6. Gerstberger, Rüdiger: 25 articles (01/2022 - 01/2002)
7. Sung, Lillian: 25 articles (01/2022 - 12/2003)
8. Zhang, Li: 25 articles (01/2022 - 05/2004)
9. Steiner, Alexandre A: 25 articles (01/2018 - 02/2002)
10. Rigante, Donato: 23 articles (10/2021 - 11/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Fever:
1. Anti-Bacterial Agents (Antibiotics)IBA
2. Acetaminophen (Paracetamol)FDA LinkGeneric
3. Adrenal Cortex Hormones (Corticosteroids)IBA
4. SteroidsIBA
5. AntipyreticsIBA
6. C-Reactive ProteinIBA
7. Ibuprofen (Motrin)FDA LinkGeneric
8. Prednisolone (Predate)FDA LinkGeneric
9. VaccinesIBA
01/01/2018 - "These findings indicate that vaccination with a single dose of attenuated rVSV-N4CT1 vectors each expressing a single filovirus GP may provide protection against the filoviruses most commonly responsible for outbreaks of hemorrhagic fever in sub-Saharan Africa.IMPORTANCE The West African Ebola virus Zaire outbreak in 2013 showed that the disease was not only a regional concern, but a worldwide problem, and highlighted the need for a safe and efficacious vaccine to be administered to the populace. "
04/27/2005 - "A safe and effective pan-filovirus vaccine is highly desirable since the filoviruses Ebola virus (EBOV) and Marburg virus (MARV) cause highly lethal disease typified by unimpeded viral replication and severe hemorrhagic fever. "
06/01/2009 - "The two-plasmid, high efficiency aspects of this Junin virus reverse genetics system show great promise for addressing important questions regarding arenavirus hemorrhagic fever disease and for development of precisely attenuated live arenavirus vaccines."
07/15/2007 - "To enhance statistical power, an analysis was performed using pooled data from the 2 trials; this pooling of data was justified by the following facts: epidemiologic surveillance and microbiological methods were identical, the trials overlapped during 22 of the 36 months of follow-up in each trial, the estimates of efficacy against paratyphoid B fever in the 2 trials were roughly similar, and the ratio of follow-up of vaccine recipients to control subjects in both trials was ~1 : 1. In the pooled analysis, Ty21a conferred significant protection against paratyphoid B fever (efficacy, 49%; 95% confidence interval, 8%-73%; P=.019)."
02/12/1994 - "The mean duration and severity of the pyrexia among the vaccinated ponies was significantly less (P < 0.01) than among the controls, and the excretion of virus was almost eliminated, thus demonstrating the protective efficacy of the vaccines 15 months after vaccination. "
10. Intravenous Immunoglobulins (IVIG)FDA Link

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)
4. Length of Stay
5. Catheters